PRESS RELEASE published on 12/03/2025 at 17:40, 11 months 5 days ago Form 8.3 - ESCATEC Holdings Ltd.: Cicor Technologies Ltd. ESCATEC Holdings Ltd. discloses a stake of 3.0022% in Cicor Technologies Ltd. through 137.048 CHF 10.00 registered securities as of 04.11.2025 Stake Disclosure Cicor Technologies Ltd. ESCATEC Holdings Ltd. 3.0022% 137.048 CHF
BRIEF published on 12/03/2025 at 10:35, 11 months 5 days ago Dévoilement de la participation de la Banque Cantonale de Zurich dans Cicor Technologies SA Investissement Code De Prise De Contrôle Cicor Technologies Banque Cantonale De Zurich Information Sur Les Valeurs Mobilières
BRIEF published on 12/03/2025 at 10:35, 11 months 5 days ago Zürcher Kantonalbank's Stake in Cicor Technologies Ltd. Unveiled Investment Takeover Code Securities Disclosure Cicor Technologies Zürcher Kantonalbank
PRESS RELEASE published on 12/03/2025 at 10:30, 11 months 5 days ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd. Zürcher Kantonalbank discloses a 1.04% ownership position in Cicor Technologies Ltd. with 47,709 securities held. Transactions include purchases of CHF 10.00 registered securities Securities Transactions Zürcher Kantonalbank Cicor Technologies Ltd. 1.04% Ownership CHF 10.00 Registered
BRIEF published on 12/02/2025 at 11:50, 11 months 6 days ago Zürcher Kantonalbank Discloses Stake in Cicor Technologies Ltd. Takeover Code Stake Disclosure Stock Sale Cicor Technologies Zürcher Kantonalbank
BRIEF published on 12/02/2025 at 11:50, 11 months 6 days ago La Banque Cantonale de Zurich divulgue sa participation dans Cicor Technologies SA. Code De Prise De Contrôle Déclaration De Participation Cicor Technologies Vente D'actions Banque Cantonale De Zurich
PRESS RELEASE published on 12/02/2025 at 11:45, 11 months 6 days ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd. Zurcher Kantonalbank discloses a 1.04% stake in Cicor Technologies Ltd. on 1st December 2025. No other disclosures made Financial Disclosure Stake Disclosure Zürcher Kantonalbank Cicor Technologies Ltd. 1.04%
BRIEF published on 12/01/2025 at 14:05, 11 months 7 days ago Zürcher Kantonalbank Discloses Position in Cicor Technologies Ltd. Securities Form 8.3 Disclosure Zürcher Kantonalbank Cicor Technologies Ltd.
BRIEF published on 12/01/2025 at 14:05, 11 months 7 days ago La Banque Cantonale de Zurich annonce sa position dans Cicor Technologies SA. Titres Divulgation Formulaire 8.3 Banque Cantonale De Zurich Cicor Technologies Ltd.
PRESS RELEASE published on 12/01/2025 at 14:00, 11 months 7 days ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd. Zürcher Kantonalbank discloses 1.04% interest in Cicor Technologies Ltd. on 28th Nov 2025 according to Form 8.3 under Rule 8.3 of the Takeover Code Form 8.3 Disclosure Zürcher Kantonalbank Cicor Technologies Ltd. 1.04% Interest
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:15, 32 minutes ago EQS-Adhoc: Airbus SE: Airbus commences multi-year share buyback programme, with launch of the first tranche
Published on 11/09/2026 at 08:05, 42 minutes ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 47 minutes ago Custodian Property Income REIT plc: Further momentum with majority share-based acquisition strategy, purchasing an £11.0m property portfolio from eight syndicated investment vehicles
Published on 11/09/2026 at 07:00, 1 hour 47 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 47 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 47 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 47 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
